Debbie Mendelson is an accomplished Rare Disease Account Executive at Biogen since May 2012, specializing in spinal muscular atrophy (SMA) business management and market development. Recognized with the Presidents Club and Imagineer Award in 2022, Debbie has also held roles in Biogen's Digital Health and Commercial Learning divisions, contributing to the launch of digital mental health solutions and the historic Aducanumab launch. Prior experience includes positions at AstraZeneca, where notable achievements included a Regional Rock Star Award and significant market share growth for Seroquel XR. Debbie's professional journey began at Qwest and Kaplan Test Prep and Admissions, complemented by a Bachelor's degree in Business Administration from the University of Arizona and an MBA in Marketing and Technologies from Arizona State University.
This person is not in any teams
This person is not in any offices